Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IL2RG |
| Upstream (Parents) |
|---|
| (<<) RAC2 → IL2RG |
| (<<) CD37 → IL2RG |
| (<<) CD3E → IL2RG |
| (<<) TRAC///TRAJ17///TRAV20///TRA@ → IL2RG |
| Downstream (Children) |
|---|
| IL2RG → SGEF (>>) |
| IL2RG → LYZ (>>) |
| IL2RG → RAC2 (>>) |
| IL2RG → CD74 (>>) |
| IL2RG → APOBEC3F///APOBEC3G (>>) |
| IL2RG → HLA-C (>>) |
| IL2RG → CD40 (>>) |
| IL2RG → CD37 (>>) |
| IL2RG → CD3E (>>) |
| IL2RG → ZBP1 (>>) |
| IL2RG → KHDC1///SPA17 (>>) |
| IL2RG → CD4 (>>) |
| IL2RG → CD7 (>>) |
| IL2RG → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A (>>) |
| IL2RG → HLA-B (>>) |
| IL2RG → SIPA1L2 (>>) |
| IL2RG → CTSW (>>) |
| IL2RG → HLA-G (>>) |
| IL2RG → IL18BP (>>) |
| IL2RG → SEPT1 (>>) |
| IL2RG → NFKB2 (>>) |
